Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter July 2018

News: New UK consortium looks to make breakthrough in gene therapy manufacture
Plasticell, alongside Great Ormond Street Hospital and the UCL Institute of Child Health, have announced they will collaborate to develop technology to better develop and manufacture gene therapies. Plasticell revealed that the initial targets for the newly-formed consortium will be to work on rare inherited disorders of the immune system, including chronic granulomatous disease.

News: FDA Aims to Facilitate Gene Therapy Development for Hemophilia, Rare Diseases
Significant progress has been made in gene therapy research and development over the years, with promise to treat and cure some of the most complex diseases. In a statement, FDA Commissioner Scott Gottlieb, MD, announced the agency’s latest efforts to speed up the path to approval for gene therapies, specifically for certain specialty and rare diseases. To help expedite advancement in the field, the FDA has released a new policy framework for the development, review, and approval of gene therapies to address the challenges of bringing these drugs to market.

Conference: 4th Annual CAR-TCR Summit 2018
What do you think comes after the first ground-breaking approval of a CAR-T therapy? I think it's even more drive to progress the field further, bigger and better CAR-Ts, advancing clinical trials, creating and building new infrastructures physically and virtually, and bringing together all the stakeholders in this field to bring life changing therapies to patients around the world.

The CAR-TCR Summit (September 4-7 2018, Boston, MA) is your comprehensive, one-stop shop for all things CAR-TCR from early discovery thorough to market access. As part of the meeting you can leverage the experience from those leaders first to market, whilst unveiling the next generation technologies and breakthroughs being developed to enhance CAR-TCR efficacy in solid tumor indications.


Conference: Advanced Therapies Commercialisation Congress
2-3 October 2018 | Amsterdam, The Netherlands
Novel Strategies for Balancing Cost, Access and Quality for Next-Generation Therapies

The Advanced Therapies Commercialisation Congress is a collaborative, multi-stakeholder meeting for exchanging views and exploring business approaches for the evolving ATMP segment. This congress convenes industry executives, public policy makers, academia and other professionals in the advanced therapies community to address the key barriers and exciting opportunities on the journey to commercialisation of these innovative technologies. Download the programme here.


- 23 - 24 July 2018, Annual Congress on Advanced Tissue Science and Regenerative Medicine, Rome, Italy
- 26 - 28 July 2018, The 24th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokyo, Japan
- 13 - 17 August 2018, Bioprocessing Summit 2018 - Gene Therapy, Boston, MA
- 20 - 21 August 2018, EuroSciCon Conference on Cell and Gene Therapy, Amsterdam, The Netherlands
- 4 - 7 September 2018, 4th Annual CAR-TCR Summit 2018, Boston, MA
- 10 - 11 September 2018, International Conference on Cell and Gene Therapy, Dublin, Ireland
- 13 - 15 September 2018, First International Conference on Lymphocyte Engineering (ICLE 2018), Madrid, Spain
- 2 – 3 October 2018, Advanced Therapies Commercialisation Congress, Amsterdam, The Netherlands
- 16 – 19 October 2018, XXVI Congress of the European Society of Gene and Cell Therapy (ESGCT), Lausanne, Swizterland
- 24 – 25 October 2018, Annual Congress on CRISPR-Cas9 Technology, Boston, MA
- 25 – 26 October 2018, 4th Annual Cell & Gene Therapy Congress, London, UK
- 6-8 November 2018, World Orphan Drug Congress 2018, Barcelona, Spain
- 8-9 November 2018, 4th Annual Genome Editing UK Congress, London, UK
- 9-10 November 2018, 2nd Annual Summit on Cell Therapy and Stem Cell Research 2018 Conference, Atlanta, GA
- 23 November 2018, British Society for Gene and Cell Therapy (BSGCT) Annual Conference Autumn 2018, London, UK
- 3 – 5 April 2019, 4th Spring school of the European Society of Gene and Cell Therapy (ESGCT), Naples, Italy
- 29 April - 2 May 2019, American Society of Gene and Cell Therapy (ASGCT) 22th Annual Meeting, Washington, DC
- 21 – 25 October 2019, XXVII Congress of the European Society of Gene and Cell Therapy (ESGCT), Barcelona, Spain


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?